Hassan Yaish
Pediatric Hematology-Oncology · Salt Lake City, UTNPI 1891874368
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Bayer at 35.9% of the total. Among pediatric hematology-oncology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $1203.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$41K
- Novo Nordisk Health Care AG$27K
- Shire North American Group Inc$22K
- Novo Nordisk AS$12K
- Octapharma USA, Inc.$5K
- Genentech USA, Inc.$4K
- plus $1K from 2 others
Across 186 payments — averaging $2302.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$208K
- Novo Nordisk AS$115K
- Shire North American Group Inc$51K
- Takeda Pharmaceuticals U.S.A., Inc.$26K
- Genentech, Inc.$14K
- Bayer$14K
- plus $1K from 1 others
What the payments were for
- Consulting fees$19,16017%
- Speaking & faculty fees$58,10051%
- Travel & lodging$34,18830%
- Food & beverage$1,6992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 36 | $40,671 |
| Novo Nordisk Health Care AG | 7 | $27,171 |
| Shire North American Group Inc | 27 | $22,355 |
| Novo Nordisk AS | 4 | $12,080 |
| Octapharma USA, Inc. | 11 | $5,473 |
| Genentech USA, Inc. | 6 | $4,372 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $900 |
| CSL Behring | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$113,148 in reported general payments places this provider in the 90th percentile of 24 pediatric hematology-oncology providers in Utah.
Other pediatric hematology-oncology in Salt Lake City
- Richard LemonsSalt Lake City$753K
- Luke MaeseSalt Lake City$332K
- Julie AschSalt Lake City$62K
- Ahmad RayesSalt Lake City$5K
- Nicholas WhippleSalt Lake City$3K
- Michell Lozano ChingaSalt Lake City$1K
- Soohee ChoSalt Lake City$948
- Joseph DolanSalt Lake City$295
- Mark FluchelSalt Lake City$235
- Elaine FanSalt Lake City$229
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.